CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Pain Therapeutics Inc  (PTIE)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Pain Therapeutics Inc's Quick Ratio

PTIE's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:                        

PTIE Quick Ratio (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
Y / Y Current Liabilities Change -73.59 % -73.93 % -16.2 % 43.08 % 236.76 %
Y / Y Cash & cash equivalent Change -38.59 % -40.21 % -37.63 % -33.98 % -28.37 %
Quick Ratio MRQ 19.55 28.14 10.04 12.61 8.41
Overall Ranking # 14 # 88 # 273 # 252 # 374
Seq. Current Liabilities Change 32.78 % -69.31 % 10.96 % -41.6 % 31.09 %
Seq. Cash & cash equivalent Change -7.75 % -14.01 % -11.62 % -12.41 % -10.18 %



Quick Ratio first quarter 2017 Comment
Due to increase in Current Liabilities in the first quarter 2017, Quick Ratio fell to 19.55 below Pain Therapeutics Inc average.

Within Major Pharmaceutical Preparations industry 2 other companies have achieved higher Quick Ratio than Pain Therapeutics Inc in first quarter 2017. While Quick Ratio total ranking has improved so far to 14, from total ranking in previous quarter at 88.

Explain Quick Ratio?
What are PTIE Segments?
See Quick Ratio PTIE on the trailing twelve month basis
Quick Ratio first quarter 2017 Company Ranking
Within: No.
Industry # 3
Sector # 4
S&P 500 # 14


Quick Ratio Statistics
High Average Low
49.2 17.39 5.63
(Dec 31 2014)   (Dec 31 2012)


You need to upgrade your Flash Player


Financial Statements
Pain Therapeutics Inc's Current Liabilities $ 1 Millions Visit PTIE's Balance sheet
Pain Therapeutics Inc's Cash & cash equivalent $ 17 Millions Visit PTIE's Balance sheet
Source of PTIE's Sales Visit PTIE's Sales by Geography




Companies with similar Quick Ratio in the quarter endingMar 31 2017, within Major Pharmaceutical Preparations Industry Quick RatioMar 31 2017 MRQ Cash & cash equivalentMar 31 2017 MRQ Current Liabilities
Dipexium Pharmaceuticals, Inc.  26.98 $ 12.471  Millions$ 0.462  Millions
Medicinova Inc  21.17 $ 21.637  Millions$ 1.022  Millions
Pain Therapeutics Inc  19.55 $ 17.264  Millions$ 0.883  Millions
Cempra, Inc.  8.56 $ 202.763  Millions$ 23.697  Millions
Spring Bank Pharmaceuticals, Inc.  7.50 $ 21.100  Millions$ 2.815  Millions
Oramed Pharmaceuticals Inc.  6.01 $ 29.629  Millions$ 4.933  Millions
United Therapeutics Corp  5.52 $ 1,156.300  Millions$ 209.600  Millions
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
KNMX's Profile
Stock Price
KNMX's Financials
KNMX's Expectations
Business Description
Fundamentals
Charts & Quotes
KNMX's News
Suppliers
KNMX's Competitors
Customers & Markets
Economic Indicators
KNMX's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com